Mayzent and Deafness - a phase IV clinical study of FDA data


Deafness is found among people who take Mayzent, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Mayzent and have Deafness. It is created by eHealthMe based on reports of 7,239 people who have side effects when taking Mayzent from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 19, 2022

7,239 people reported to have side effects when taking Mayzent.
Among them, 8 people (0.11%) have Deafness.

What is Mayzent?

Mayzent has active ingredients of siponimod fumaric acid. eHealthMe is studying from 7,240 Mayzent users for its effectiveness, alternative drugs and more.

What is Deafness?

Deafness is found to be associated with 2,662 drugs and 2,164 conditions by eHealthMe.

Number of Mayzent and Deafness reports submitted per year:

Could Mayzent cause Deafness?

Gender of people who have Deafness when taking Mayzent *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Deafness when taking Mayzent *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Mayzent *:

  1. Vitamin D: 2 people, 25.00%
  2. Synthroid: 2 people, 25.00%
  3. Effexor: 2 people, 25.00%

Common side effects people have besides Deafness *:

  1. Balance Disorder: 4 people, 50.00%
  2. Hypoaesthesia (reduced sense of touch or sensation): 3 people, 37.50%
  3. Weakness: 2 people, 25.00%
  4. Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 25.00%
  5. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 25.00%
  6. Decreased Immune Responsiveness: 2 people, 25.00%
  7. Fall: 2 people, 25.00%
  8. Fatigue (feeling of tiredness): 2 people, 25.00%
  9. Gait Disturbance: 2 people, 25.00%
  10. Hypoacusis (loss of hearing): 2 people, 25.00%

Common conditions people have *:

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 50.00%
  2. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 3 people, 37.50%
  3. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 37.50%
  4. Vitamin D Decreased: 2 people, 25.00%
  5. Stress And Anxiety: 2 people, 25.00%
  6. High Blood Cholesterol: 2 people, 25.00%
  7. Depression: 2 people, 25.00%
  8. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 2 people, 25.00%
  9. Clinically Isolated Syndrome (individual's first neurological episode, caused by inflammation or demyelination of nerve tissue): 1 person, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Mayzent and have Deafness?

Check whether Deafness is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Deafness and when was it recovered:

Expand to all the drugs that have ingredients of siponimod fumaric acid:

Alternative drugs to, pros and cons of Mayzent:

Common Mayzent side effects:

Browse all side effects of Mayzent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Deafness treatments and more:

COVID vaccines that are related to Deafness:

Common drugs associated with Deafness:

All the drugs that are associated with Deafness:

Common conditions associated with Deafness:

All the conditions that are associated with Deafness:

How the study uses the data?

The study uses data from the FDA. It is based on siponimod fumaric acid (the active ingredients of Mayzent) and Mayzent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: